Foghorn Therapeutics Inc.
USD5.19
+0.12 (+2.37%)
CEO
Adrian H. Gottschalk
IPO Date
2020-10-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.02
Prev. Close
$5.07
Day Low
$4.98
Day High
$5.28
52W Low
$3.27
52W High
$6.95
Market Cap
$0.30B
Volume
0.41M
| 28,000 |
| $4.08 |
| 25 Jun 2026 | Biller Scott | director | A-Award | Acquired | 28,000 | $4.08 |
| 25 Jun 2026 | Gallagher Neil | director | A-Award | Acquired | 28,000 | $4.08 |
| 25 Jun 2026 | Mendelsohn Michael | director | A-Award | Acquired | 28,000 | $4.08 |
| 25 Jun 2026 | SMITH IAN F | director | A-Award | Acquired | 28,000 | $4.08 |
| 25 Jun 2026 | GILL SIMBA | director | A-Award | Acquired | 28,000 | $4.08 |
| 25 Jun 2026 | PARSHALL B LYNNE | director | A-Award | Acquired | 28,000 | $4.08 |
| 25 Jun 2026 | Cole Douglas G. | director | A-Award | Acquired | 28,000 | $4.08 |
| 13 Apr 2026 | GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | G-Gift | Disposed | 47,497 | $0.00 |